Term
|
Definition
* Beta lactam, no other ring attached
* Only active on G- aerobes
* Resists most Beta lactamases of G-
* Binds penicillin protein 3--> filamentouc, lysable bacteria
* IV/IM, unchanged excretion. Adjust dose for renal failure |
|
|
Term
|
Definition
* not a beta lactam
* IV/IM, oral for local effect in GIT
* For MRSA or Staph with patient allergic to beta lactam
* Local action against C diff
* Prevents removal of D-Ala in muramic acid cell wall and thus prevents cross linking. |
|
|
Term
|
Definition
* Red Man Syndrome- flushing from vessel dilation
* Hypotension, tachycardia, shock.
*Nothing to do with IgE, just drug on body action-causes histamine release
* Nephrotoxicity (with other nephrotoxic drugs) Ototoxicity |
|
|
Term
|
Definition
* NOT Beta lactam, inhibits cell wall synthesis
* Cidal vs various G+ cocci and bacilli
* NEPHROTOXIC
* Lipid carrier bactoprenol carries NAG-NAM to outside via dephosphorylation
* Bacitracin complexes w pyrophosphate to prevent dephosphorylation. |
|
|
Term
|
Definition
* topical for minor cuts and scrapes
* ophthalmic ointment for ulcerative blepharitis and bacterial conjunctivitis
* Often used with other drugs |
|
|
Term
|
Definition
* Used for short course Tx of uncomplicated UTI in women
* Mechanism:This blocks the addition of phosphoenolpyruvate to UDP-N-acetylglucosamine, the 2nd step in the in the synthesis of Park Nucleotide. Inhibits cell wall synthesis@font-face { font-family: "Times New Roman"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }p.MsoFooter, li.MsoFooter, div.MsoFooter { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }table.MsoNormalTable { font-size: 10pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; }
* Inhibits cell wall synthesis |
|
|
Term
|
Definition
* Amino sugars attached to glycosidic links to an aminocyclitol ring
* very polar polycations
* IV route, orally cleans out bowel
* Mechanism Enters G- via porin down gradient, enters cell, inhibits protein synthesis
* Cidal |
|
|
Term
Aminoglycosides, ways to Inhibit Protein Synthesis |
|
Definition
1. Inhibit initiaion of protein synthesis
2. Make faulty proteins misreading mRNA
3. Premature terminations, polyribosome turns to monoribosome. Responsible for postantiobiotic effect |
|
|
Term
Aminoglycosides Side Effects |
|
Definition
* Attain highest levels in renal cortex> reversible nephrotoxicity
* Endolymph> irreversible ototoxicity
* Degeneration of auditory nerve can lead to permanent hearing loss
Auditory Sx: tinnitus, high freq hearing loss
Vestibular: vertigo, ataxia, loss of balance
* Can accumulate in fetus! ototoxicity in neonates |
|
|
Term
|
Definition
*(generic) topical cream/ointment for burns, wounds
*prevent catheter infections, opthalmic for superficial ocular infection(then called Genoptic)
* IV Aminoglycosides
|
|
|
Term
|
Definition
* Generally intechangeable with gentamicin
* Possibly less ototoxic than gentamicin
* IV Aminoglycosides
|
|
|
Term
|
Definition
* enzyme resistant for nosocomial infections that resist gentamicin and tobramycin
*IV Aminoglycoside |
|
|
Term
|
Definition
* Neomycin and Paromomycin
* Neomycin prep for bowel surgery, topical antiinfectant
*Paromomycin kills cysts of Entamoeba histolytica which cause amebic dysentery |
|
|
Term
|
Definition
* CL= (140-Age) x(lean wt in kg)
------------------------------
72 x Serum Creatinine (mg/dL)
For WOMEN multiply 0.85
Only distribute in lean body mass due to polycationic nature do not distribute in total body mass/water. |
|
|
Term
Lean Body Weight calculation |
|
Definition
* MALE=50kg _2.3 kg for each inch over 5ft
* Female- 45.5 kg + 2.3 kg for each inch over 5 ft.
* Aminoglycoside dose: Maximum daily dose x estimated CL/normal CL |
|
|
Term
Normal Creatinine Clearance |
|
Definition
* For a 70 kg male, dosing 1x/day monitor trough
* Dose is 2-3x/day, monitor peak and trough levels
* Know the trough and peak are notable different for Amikacin vs. Gent and Tobra |
|
|
Term
Other Side Effects of Aminoglycosides |
|
Definition
* Neuromuscular Block by
1.Blocking Ca++ uptake into nerve terminal> prevent Ach release
2. Block postsynaptic Ach Receptor |
|
|
Term
|
Definition
* Broad spectrum static vs G=/G- and some intracellular organisms
* Lipid soluble
* Undergo enterhepatic cycle to have persistant drub levels
* Inihibt binding of aminoacyl tRNA to ribosome. Inhibit translation
*Grouped on duration of activity |
|
|
Term
Short Acting Tetracycline |
|
Definition
* 6-8 hours
* Tetracycline is name of drug.
* For acne |
|
|
Term
Intermediate Acting Tetracyclines |
|
Definition
* Act for about 12 hrs
* Demeclocycline
* For chronic dilutional hyponatremia in the syndrome of ADH (too much ADH)
* inhibits protein kinase in gut of renal tubule whee ADH depends to act
|
|
|
Term
|
Definition
* 16-18 hrs
* Doxycycline oral and parental, lipidphilic!
* Minocycline (next card) |
|
|
Term
Minocycline Characteristics |
|
Definition
* Long lasting tetracycline
*originally for acne
* Associated with pulmonary complications eg pulm lupus, hypersensitivity pneumonitis, pleural effusions
* Immunomodulatory and anti-inflammatory activity
* Neuroprotective?
* pigments nail skin sclera, thyroid, gums>not reversible |
|
|
Term
Minocycline Immunmodulatory Examples |
|
Definition
* Blocks synthesis of NO
* Activates microglia, decreasing neuronal damage
* Improved stroke outcome given 6-24 hours afer stroke
* Neuroprotecting in Parkinson, Huntington's ALS< MS< Moderately effective RA |
|
|
Term
Tetracycline General Side Effects |
|
Definition
* GI Upset- Take w food
* permanent brown teeth
* Slowed growth photosensitivity esp w demeclocycline
* Expired Rx> Fanconi like syndrome from nephrotoxic metabolite epianhydrotetracycline> nausea vomitting, polyuria, polydipsia, glucosuria, aminoaciduria, hyperchloremic metabolic acidosis
* absorption decreased by dairy and antacids |
|
|
Term
|
Definition
* Parenteral, long acting
* Derivative of minocycline w similar side effects
* Same Mech. as tetracycline, cidal in some species.
* Greater acitvity vs tetracycline sens G+ G- and MRSA from greater hindrance |
|
|
Term
|
Definition
* Lactone ring + 1 or more deoxy sugars
* All active against MRSA
|
|
|
Term
Macrolide Mechanism of action |
|
Definition
* inhibit translocation from A to P site
* Release peptidyl tRNA form ribosomes
* Block formation of initiation complex |
|
|
Term
|
Definition
* Active against Legionella
* Metabolites complex with w cytochrome heme, Fe+2, inhibit CYP3A4
* Prokinetic, can bind and stimulate GI motility via motilin receptors. Stimulates peristalsis, speeds gastric empyting |
|
|
Term
|
Definition
* Large lactome ring
* Mostly static sometimes Cidal
* Active against methicillin sensitive aureas, Moraxella catarrhalis, H. influenza
* Increase digoxin activity
* Immunomodulatory, esp clarithromycin
*Prolongs repolarization via K+ Channel effect> Torsades de pointes |
|
|
Term
Erythromycin Side Effects |
|
Definition
* Can prolong cardiac repolarization> Torsades de pointes. Increased risk if used w another Rx that inhibits CYP3A4>increases erythromycin
* Binds heme, inhibiting CYP3A4, increasing its and other drugs' levels ie dilitiazem, verapamil
* For some reason increases risk of sudden death
|
|
|
Term
Azithromycin Characteristics |
|
Definition
* Now used for Legionellas, community acquired pneumonia, mycobacterium avium complex
* Concentrates intracellularly
* long half life 70 hrs
Doesn't inhibit P450
* excreted unchanged in bile |
|
|
Term
Clarithromycin Characteristics |
|
Definition
* For community acquired pneumonia and mycobacterium avium complex
* Immunomodulatory: inhibit trancription for proinflammatory cytokines
* Inhibits CYP3A:
Caution using with colchicine (used for gout)>increase risk of colchicine toxicity. |
|
|
Term
|
Definition
* Ketolides are macrolide derivatives with better G+ activity
* Same mechanism as macrolides but binds 2 separate domains on ribosomes to recrease risk of resistance and have broader activity.
* |
|
|
Term
|
Definition
* A ketolide
* Used for community acquired respiratory infections
* Concentrates in pulmonary tissues and WBCs
* Active vs Beta lactam and macrolide resistant organisms
* Inhibits CYP3A4 Prolongs Q-T interval
* Rarely, serious hepatotoxicity
BBW Contraindicated if myasthenia gravis, life threatening respiratory failure |
|
|
Term
Tigecycline Uses and Side Effects |
|
Definition
* complicated skin and intraabdominal infections, community acquires bacterial pneumonia
* Side effects: N&V, increased risk of mortality if hopsital acquires pneumonia, esp if ventilator asspciated, complicated intra ab infection or complicated skin and skin structure infection
*Hepatic excretion, decrease dose if hepatic impairment |
|
|